Welcome to our dedicated page for Senestech news (Ticker: SNES), a resource for investors and traders seeking the latest updates and insights on Senestech stock.
SenesTech, Inc. develops and commercializes fertility-control products for managing animal pest populations, with current products focused on rat and mouse populations. Its product names include ContraPest, Evolve Rat, and Evolve Mouse, which are used within pest-management programs as alternatives or complements to traditional rodent-control methods.
Company news centers on Evolve commercialization, e-commerce and direct-to-consumer sales channels, Amazon marketplace management, field-study data on rodent activity, product approvals in international markets, quarterly and annual financial results, capital runway commentary, and executive leadership or board governance updates.
SenesTech (NASDAQ: SNES) will present at the Lytham Partners 2026 Consumer & Technology Investor Summit via webcast on Tuesday, August 18, 2026, at 1:30 p.m. ET. Investors can access the live stream and replay through the summit home page or the dedicated SenesTech webcast link.
SenesTech (NASDAQ: SNES) reported record Q2 2026 revenue of $770,000, up 56% from Q1 2026 and 23% year over year, driven by rapid e-commerce growth. E-commerce revenue reached a record $511,000, more than tripling sequentially and surpassing direct B2B revenue for the first time, with Amazon revenue jumping to $349,000 in the first full quarter of in-house management.
Gross profit rose to a record $567,000, with gross margin improving to a company-record 73.6%. Net loss was $1.8 million, better than Q1 2026 but higher than Q2 2025. Adjusted EBITDA loss was $1.4 million. Cash and equivalents totaled $5.1 million at June 30, 2026. July 2026 e-commerce revenue and subscription revenue each set new monthly records.
SenesTech (NASDAQ: SNES) has launched new rodent infestation assessment services for B2B customers, complementing its existing implementation and deployment support. The services aim to quantify the scope of rodent problems so SenesTech can recommend tailored strategies using fertility control products, other Integrated Pest Management (IPM) practices, or both.
Assessment can be delivered as a turnkey service or performed by customers using SenesTech’s tracking products and internally developed AI analysis tool, with the company assisting in data interpretation. Deployed starting in July across targeted B2B verticals, these services are intended, according to SenesTech, to deepen customer relationships, improve implementation outcomes and create an additional revenue opportunity.
SenesTech (NASDAQ: SNES) reported that its active online subscription customer base, spanning direct-to-consumer and business-to-business clients, more than doubled in the second quarter of 2026 versus the first quarter, reaching a record level. According to SenesTech, this supports its recurring revenue model and improves long-term revenue visibility.
The company said its overall e-commerce business grew 186% quarter-over-quarter, driven in part by subscriber growth and investments in Amazon, SenesTech.com, Shopify and digital marketing. Subscriptions for its Evolve and ContraPest rodent birth control products are positioned to provide predictable, ongoing demand across consumer and commercial markets.
SenesTech (NASDAQ: SNES) will release its second quarter 2026 financial results, for the period ended June 30, 2026, after market close on Wednesday, August 5, 2026. A conference call and live webcast to review the results will follow at 5:00 p.m. Eastern time.
SenesTech (NASDAQ: SNES) reported successful use of Evolve Rat Birth Control at a 400-acre farm in Dalhart, Texas. The agricultural operation, which uses underground drip irrigation, saw onsite-estimated rodent activity decline about 80%, with fewer leaks and reduced irrigation tape damage after several months of Evolve deployment.
SenesTech (NASDAQ: SNES) appointed veteran sales executive Jack Karabees as Executive Vice President of Sales. He will lead the sales organization, focusing on revenue growth, broader market penetration and stronger customer relationships.
Karabees has decades of B2B sales leadership and has already consulted for SenesTech on commercial strategy.
SenesTech (NASDAQ: SNES) announced a distribution agreement to expand its Evolve Rodent Birth Control products into Bermuda via Animal and Garden House. The company highlights Bermuda's tightly regulated, environmentally sensitive island ecosystem and positions Evolve as a non-lethal, fertility-based rodent control option. Existing regional deployments include the U.S. Virgin Islands and Belize.
SenesTech (NASDAQ: SNES) announced that its board revised the proposed amendment to the 2018 Equity Incentive Plan ahead of the June 9, 2026 annual meeting. The revised proposal would add 1.2 million shares for future equity awards, reduced from 1.7 million previously contemplated.
Stockholders who already voted in favor of Proposal No. 3 will be deemed to support the revised terms unless they change their vote.
SenesTech (NASDAQ: SNES), a company focused on fertility control for managing animal pest populations and maker of EPA-compliant Rodent Birth Control products, will participate in the virtual Lytham Partners Spring 2026 Investor Conference on Thursday, May 28, 2026.
The company will deliver a webcast presentation at 2:30 p.m. ET, accessible via the conference home page or direct webinar link. The webcast will be available for replay, and management will also hold virtual one-on-one meetings with investors during the event.